
HOOKIPA Pharma Inc
NASDAQ:HOOK

Intrinsic Value
The intrinsic value of one
HOOK
stock under the Base Case scenario is
4.49
USD.
Compared to the current market price of 1.04 USD,
HOOKIPA Pharma Inc
is
Undervalued by 77%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
HOOKIPA Pharma Inc
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
HOOKIPA Pharma Inc
Balance Sheet Decomposition
HOOKIPA Pharma Inc
Current Assets | 60.1m |
Cash & Short-Term Investments | 40.3m |
Receivables | 8.3m |
Other Current Assets | 11.5m |
Non-Current Assets | 1.2m |
PP&E | 686k |
Other Non-Current Assets | 479k |
Free Cash Flow Analysis
HOOKIPA Pharma Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
HOOKIPA Pharma Inc
Revenue
|
9.4m
USD
|
Operating Expenses
|
-84.3m
USD
|
Operating Income
|
-74.9m
USD
|
Other Expenses
|
1.6m
USD
|
Net Income
|
-73.3m
USD
|
HOOK Profitability Score
Profitability Due Diligence
HOOKIPA Pharma Inc's profitability score is 11/100. The higher the profitability score, the more profitable the company is.

Score
HOOKIPA Pharma Inc's profitability score is 11/100. The higher the profitability score, the more profitable the company is.
HOOK Solvency Score
Solvency Due Diligence
HOOKIPA Pharma Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Score
HOOKIPA Pharma Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HOOK Price Targets Summary
HOOKIPA Pharma Inc
Dividends
Current shareholder yield for HOOK is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
HOOK
stock under the Base Case scenario is
4.49
USD.
Compared to the current market price of 1.04 USD,
HOOKIPA Pharma Inc
is
Undervalued by 77%.